Blog
RSS FeedPosted by Michael Wonder on 06 Dec 2018
Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly
5 December 2018 - Professor Paul Workman, discusses the findings of the ICR's new drug access report, which asks how we ...
Posted by Michael Wonder on 04 Dec 2018
Flexibility on cancer drugs approval will foster innovation
4 December 2018 - Between 2000 and 2016, no new drugs were approved for cancers of the brain, and there were ...
Posted by Michael Wonder on 10 Oct 2018
New drugs: how much are governments paying for innovation?
10 October 2018 - The medical innovation debate is also heated up due to the ongoing discussion on Health Technology Assessments. ...
Posted by Michael Wonder on 03 Oct 2018
CMS accelerates innovation and promotes patient access to medical technology
3 October 2018 - Reforms to Medicare’s Local Coverage Determination process will increase transparency and patient engagement in order to ...
Posted by Michael Wonder on 02 Oct 2018
This startup wants to score you cheap prescription drugs. Now it's offering home delivery.
2 October 2018 - Digital health startup Blink Health will now provide customers free home delivery for its prescription drug ...
Posted by Michael Wonder on 26 Sep 2018
The health industry as an economic priority for Victoria, joint statement
26 September 2018 - Victoria has world-leading competitive advantages in the health industry, which encompasses health and medical research, biotechnology, ...
Posted by Michael Wonder on 17 Sep 2018
Antimicrobial resistance: FDA discusses reimbursement reforms
17 September 2018 - Reimbursement reforms for antimicrobial treatments could include “a mix of milestone payments and subscription fees for ...
Posted by Michael Wonder on 30 Aug 2018
FDA’s comprehensive effort to advance new innovations: initiatives to modernise for innovation
29 August 2018 - Our longstanding goal for medical care is to ensure that the right drug or device is delivered ...
Posted by Michael Wonder on 29 Aug 2018
FDA launches new pilot to advance innovative clinical trial designs as part of agency’s broader program to modernise drug development and promote innovation in drugs targeted to unmet needs
29 August 2018 - Today, the U.S. FDA announced a new pilot program (“Complex Innovative Designs Pilot Meeting Program”) in which ...
Posted by Michael Wonder on 29 Aug 2018
Developing tools to support digital health and medtech innovation
8 August 2018 - NICE is involved in two key initiatives with national partners to achieve these aims by developing standards ...
Posted by Michael Wonder on 16 Aug 2018
Statement from FDA Commissioner on advancing the science and regulation of live microbiome-based products used to prevent, treat, or cure diseases in humans
16 August 2018 - Over the last several years, there’s been growing scientific and public interest in the role of microorganisms ...
Posted by Michael Wonder on 01 Aug 2018
FDA supports critical research to spur innovation for continuous manufacturing technology to support and advance drug and biologics development
1 August 2018 - We know that novel manufacturing technologies for both small-molecule drugs and biological products have great potential to ...
Posted by Michael Wonder on 12 Jul 2018
After feuding with drug middlemen, startup fields a competitor
12 July 2018 - Blue Eagle Health manages a 33,000 pharmacy network for Blink. ...
Posted by Michael Wonder on 11 Jul 2018
Defining innovation with respect to new medicines: a systematic review from a payer perspective
11 July 2018 - The aim of this study was to investigate how innovation is defined with respect to new ...
Posted by Michael Wonder on 06 Jun 2018
Big pharma wants to invest more in Australian biotech says Greg Hunt
6 June 2018 - Big pharma is "looking at Australia as the next destination in the developed world, the emerging first-world ...